NO982867D0 - Nye substituerte 4-(1H-benzimidazol-2-yl)£1,4|diazepaner som er anvendbare for behandling av allergiske sykdommer - Google Patents

Nye substituerte 4-(1H-benzimidazol-2-yl)£1,4|diazepaner som er anvendbare for behandling av allergiske sykdommer

Info

Publication number
NO982867D0
NO982867D0 NO982867A NO982867A NO982867D0 NO 982867 D0 NO982867 D0 NO 982867D0 NO 982867 A NO982867 A NO 982867A NO 982867 A NO982867 A NO 982867A NO 982867 D0 NO982867 D0 NO 982867D0
Authority
NO
Norway
Prior art keywords
benzimidazol
treatment
allergic diseases
newly substituted
diazepanes
Prior art date
Application number
NO982867A
Other languages
English (en)
Other versions
NO982867L (no
NO316932B1 (no
Inventor
John Michael Kane
George Daniel Maynard
Timothy Paul Burkholder
Larry Don Bratton
Christopher Robin Dalton
Braulio Santiago
Elizabeth Mary Kudlacz
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO982867D0 publication Critical patent/NO982867D0/no
Publication of NO982867L publication Critical patent/NO982867L/no
Publication of NO316932B1 publication Critical patent/NO316932B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19982867A 1995-12-20 1998-06-19 Nye, substituerte 4-(1H-benzimidazol-2-yl)[1,4]diazepaner som er anvendbare for behandling av allergiske sykdommer, fremgangsmate for fremstilling av disse, samt farmasoytisk preparat inneholdende disse NO316932B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58000495A 1995-12-20 1995-12-20
US73641196A 1996-10-24 1996-10-24
PCT/US1996/019524 WO1997022604A1 (en) 1995-12-20 1996-12-04 Novel substituted 4-(1h-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases

Publications (3)

Publication Number Publication Date
NO982867D0 true NO982867D0 (no) 1998-06-19
NO982867L NO982867L (no) 1998-08-19
NO316932B1 NO316932B1 (no) 2004-06-28

Family

ID=27077922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19982867A NO316932B1 (no) 1995-12-20 1998-06-19 Nye, substituerte 4-(1H-benzimidazol-2-yl)[1,4]diazepaner som er anvendbare for behandling av allergiske sykdommer, fremgangsmate for fremstilling av disse, samt farmasoytisk preparat inneholdende disse

Country Status (20)

Country Link
EP (1) EP0874843B1 (no)
JP (1) JP2000500772A (no)
KR (1) KR20000064487A (no)
CN (1) CN1080262C (no)
AR (1) AR005120A1 (no)
AT (1) ATE221883T1 (no)
AU (1) AU707914B2 (no)
BR (1) BR9612074A (no)
CA (1) CA2241827C (no)
DE (1) DE69622889T2 (no)
DK (1) DK0874843T3 (no)
ES (1) ES2177827T3 (no)
HK (1) HK1017684A1 (no)
IL (1) IL125002A0 (no)
MX (1) MX9804991A (no)
NO (1) NO316932B1 (no)
NZ (1) NZ325581A (no)
PT (1) PT874843E (no)
TW (1) TW335395B (no)
WO (1) WO1997022604A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194406B1 (en) * 1995-12-20 2001-02-27 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
US6423704B2 (en) 1995-12-20 2002-07-23 Aventis Pharmaceuticals Inc. Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
US6552188B2 (en) * 2001-06-29 2003-04-22 Kowa Co., Ltd. Unsymmetrical cyclic diamine compound
JP5014983B2 (ja) 2004-05-07 2012-08-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 11−ベータヒドロキシステロイドデヒドロゲナーゼ阻害剤としてのピロリジン−2−オン及びピペリジン−2−オン誘導体
ATE397586T1 (de) 2004-05-07 2008-06-15 Janssen Pharmaceutica Nv Adamantyl pyrrolidin-2-on-derivate als 11-beta hydroxysteroid dehydrogenas inhibitoren
UA87328C2 (en) 2004-08-30 2009-07-10 Янссен Фармацевтика Н.В. N-2 adamantanyl-2-phenoxy-acetamide derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
EP1786774B1 (en) 2004-08-30 2009-10-14 Janssen Pharmaceutica N.V. Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
DE602005017159D1 (de) 2004-08-30 2009-11-26 Janssen Pharmaceutica Nv Oxysteroid-dehydrogenase-inhibitoren
WO2008090114A1 (en) 2007-01-24 2008-07-31 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
CN105646306B (zh) * 2015-12-11 2020-06-30 广东莱佛士制药技术有限公司 一种4-甲硫基苯乙酸的制备方法
EP3886854A4 (en) 2018-11-30 2022-07-06 Nuvation Bio Inc. PYRROLE AND PYRAZOLE COMPOUNDS AND METHODS OF USE THERE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676054B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2676055B1 (fr) * 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
NZ267209A (en) * 1993-05-06 1997-09-22 Merrell Dow Pharma Substituted pyrrolidin-3-yl-alkyl-piperidine derivatives, preparation and pharmaceutical compositions thereof
WO1994027973A1 (fr) * 1993-05-20 1994-12-08 Kissei Pharmaceutical Co., Ltd. Derive 1-(2-benzimidazolyl)-1,5-diazacyclooctane
EP0777666B1 (en) * 1994-08-25 1999-03-03 Merrell Pharmaceuticals Inc. Substituted piperidines useful for the treatment of allergic diseases

Also Published As

Publication number Publication date
AU707914B2 (en) 1999-07-22
DE69622889D1 (de) 2002-09-12
BR9612074A (pt) 1999-03-30
AR005120A1 (es) 1999-04-14
AU1411997A (en) 1997-07-14
CN1080262C (zh) 2002-03-06
EP0874843A1 (en) 1998-11-04
NO982867L (no) 1998-08-19
CA2241827C (en) 2002-04-30
DE69622889T2 (de) 2003-04-10
NZ325581A (en) 2000-03-27
MX9804991A (es) 1998-09-30
JP2000500772A (ja) 2000-01-25
ATE221883T1 (de) 2002-08-15
WO1997022604A1 (en) 1997-06-26
PT874843E (pt) 2002-12-31
NO316932B1 (no) 2004-06-28
CA2241827A1 (en) 1997-06-26
KR20000064487A (ko) 2000-11-06
CN1207097A (zh) 1999-02-03
ES2177827T3 (es) 2002-12-16
EP0874843B1 (en) 2002-08-07
TW335395B (en) 1998-07-01
IL125002A0 (en) 1999-01-26
DK0874843T3 (da) 2002-11-25
HK1017684A1 (en) 1999-11-26

Similar Documents

Publication Publication Date Title
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO914027D0 (no) Fremgangsmaate for fremstilling av nye substituerte azetidinoner
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
NO982867L (no) Nye substituerte 4-(1H-benzimidazol-2-yl)£1,4|diazepaner som er anvendbare for behandling av allergiske sykdommer
FI953899A0 (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
HUP9900927A3 (en) Substituted 4-(1h-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
NO976112D0 (no) 1,6-disubstituerte isokromaner for behandling av migrene
ITMI940317A0 (it) Procedimento per la produzione di gamma-butirrolattone
FI931033A (fi) Foerfarande foer framstaellning av dialkyl-2,3-pyridindikarboxylat och derivat daerav ur a,b-omaettade oximer och aminobutendioat
NO913391D0 (no) Fremgangsmaate for fremstilling av nye hetrazepinoide syreamider.
NO913117L (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
FI973644A (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
FI941149A0 (fi) 2,4-diamino-3-hydroksikarboksyylihapon johdannaisia
NO983829D0 (no) Nye substituerte N-metyl-N-(4-(4-(1H-benzimidazol-2-yl)£1,4|diazepan-1-yl)-2-(aryl)butyl)benzamider som er anvendbare for behandling av allergiske sykdommer
NO911118L (no) Fremgangsmaate for fremstilling av nye 8-sulfamylmethylen-2-amino-tetraliner.
NO910782D0 (no) Nye krystallinske former av (s)-norfluoksetin.
NO985929D0 (no) Nye former av organiske salter av N'N-diacetylcystin
NO965165L (no) Anvendelse av 8,9-dehydroestron som en antioksydant
SI0874843T1 (en) Substituted 4-(1h-benzimidazol-2-yl) 1,4)diazepanes useful for the treatment of allergic diseases
IT1275594B1 (it) Epimeri del (22rs)-n-(1,1,1-trifluoro-2-fenilprop-2-il)-3-osso -4-aza-5alfa-androst-1-ene-17beta-carbossammide
TR199600607A2 (tr) Insektisidlerin iticiligini azaltmaya mahsus para-hidroksifenilasetik asit.
ZA9610602B (en) Novel substituted 4-(1H-benzimidazol-2-yl)¬1,4¾diazepanes useful for the treatment of allergic diseases
LV5046A3 (lv) 3-(2,2,2-trimetilhidrazinij)propionata dihidrata iegusanas panemiens
ITVR920084A0 (it) Procedimento di produzione di stanghetta per occhiale, nonche' stanghetta realizzata mediante tale procedimento
FI954263A0 (fi) Vid skjutning anvaendbart foerfarande foer bestaemning av traeffar

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees